# Cabergoline

NDC: 50742-118
Generic name: Cabergoline
Labeler / Manufacturer: Ingenus Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20180809

FDA application: ANDA204735

## Active ingredients

- CABERGOLINE: .5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50742-118"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50742-118
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=57cbd81e-fdb9-4060-80ee-6e8581c463a4